Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of single oral administration of Yokukansan (TJ-54) in healthy adults and elderly subjects
jRCT1080224536Phase 1Completed
- Sponsor
- Tsumura & Co.
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of yokukansan, sponsored by Tsumura & Co. Primary endpoint: Primary pharmacokinetic endpoints. Started Jan 2019; status: completed.
02
Drugs
yokukansan
Beyond the preview
Go deeper on jRCT1080224536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224536.